Dexcom is recalling 19 models of its continuous glucose monitoring receivers due to a speaker malfunction that could prevent alerts for dangerous blood sugar levels.
The affected devices are models Dexcom G6, G7, ONE and ONE+ receivers, according to a July 17 news release from the FDA. The recall has been classified as Class I by the agency due to the risk of injury or death.
The receivers are used to alert users when their blood sugar is dangerously high or low and if the speaker fails, individuals could miss critical warnings, the release said.
The company began notifying customers June 9, urging them to check their receiver’s serial number and request a free replacement if affected. Fifty-six injuries have been reported.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
